1. In Vivo
  2. >>Innovation

The Role Of Data Encryption In Cyber Attacks

 
• By Nigel Thorpe

The health care and pharma industries are particularly vulnerable to a cyber-attack, also experiencing the highest cost of a breach. New ways of seamlessly encrypting data may be the way forward.    

Cybersecurity
• Source: Shutterstock

The pharmaceutical industry is certainly no stranger to cyber-attacks. Merck & Co., Inc.'s 2017 'NotPetya' cyberattack is still looming large over the industry, as the legal ramifications - including Merck's $1.4bn insurance claim – continue into 2023. (Also see "Merck Cyberattack Recovery: Congress Scrutinizes Manufacturing Problems" - Pink Sheet, 21 September, 2017.)

More recently, AstraZeneca PLC is in the spotlight for a data breach which saw credentials for one of its...

Welcome to In Vivo

Create an account to read this article

Already a subscriber?

More from Innovation

As Pricing Pressures Mount, Biopharma Turns To AI To Reduce Trial Failure Rates

 
• By David Wild

With drug pricing policies potentially squeezing industry margins, companies are increasingly turning to AI-driven trial optimization to rescue sub-optimal studies and accelerate development timelines.

How Annexon Reclaimed Its Geographic Atrophy Program After Phase II Miss

The biotech's C1q inhibitor, vonaprument, preserved vision but missed the primary Phase II endpoint on lesion growth. The stakes are high for a Phase III with a different primary endpoint.

Rising Leaders 2025: Noam Solomon’s Quest To Create A ‘Google Maps’ Of the Immune System

 
• By David Wild

The mathematician-turned-CEO is building an atlas of clinical immune biology to revolutionize precision medicine.

Three Approaches, One Goal: How Digital Twin Technologies Can Differ

 
• By David Wild

Three digital twin approaches compete: image-based precision, phenotypic modeling and massive data aggregation.

More from In Vivo

How Annexon Reclaimed Its Geographic Atrophy Program After Phase II Miss

The biotech's C1q inhibitor, vonaprument, preserved vision but missed the primary Phase II endpoint on lesion growth. The stakes are high for a Phase III with a different primary endpoint.

Deals Shaping The Industry, August 2025

An interactive look at pharma, medtech and diagnostics deals made during August 2025. Data courtesy of Biomedtracker.

Rising Leaders 2025: Noam Solomon’s Quest To Create A ‘Google Maps’ Of the Immune System

 
• By David Wild

The mathematician-turned-CEO is building an atlas of clinical immune biology to revolutionize precision medicine.